Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board denied higher ratings for migraines, lumbosacral strain, and left knee strain with tendonitis, but granted a 10 percent rating for atopic dermatitis of the left lower chest. The claim for service connection for sinusitis was also denied.

The Board denied the Veteran's claim for service connection for chloracne, finding no current disability and insufficient evidence of in-service exposure or a link to service.

The Board denied the veteran's appeal for an increased disability evaluation for dermatitis, maintaining the current 10 percent rating.

The Board denied the claim for a total disability rating based on individual unemployability due to service-connected disabilities prior to March 1, 2018.

The Board granted service connection for hypertension, Parkinsonism, residuals of skin cancer, actinic keratosis, and non-specific dermatitis based on the Veteran's exposure to herbicide agents during active military service.

The Board denied service connection for various conditions and denied initial ratings for several disabilities, while granting a 30% rating for the left foot disability and a 40% rating for the back disability.

The Board remands the claims for service connection for pseudofolliculitis barbae, allergic rhinitis, irritable bowel syndrome (IBS), migraine headaches, and sleep apnea to correct a pre-decisional duty to assist error.

The Board denied the veteran's claims for a compensable rating for pseudofolliculitis barbae and service connection for dermatosis of the hands, but remanded the claim for service connection for a neurological condition.

The Board denied the Veteran's claims for service connection and increased ratings, as well as remanded certain issues for further consideration.

The Board denied service connection for various conditions, including iron deficiency anemia, acute pharyngitis, adenovirus infection, chlamydia, female sexual arousal disorder (secondary to chlamydia), low back pain, left knee pain, right knee pain, right wrist pain, dermatitis/eczema, acne, and tinnitus.

The appeal with respect to the determination that a duty to assist error has been identified during the higher-level review for gastroesophageal reflux disease (GERD) is dismissed.

The Board granted service connection for a left hip disability, GERD, and dermatitis. The claims for a bowel disability and obstructive sleep apnea were denied. The remaining issues are remanded.

The Board denied increased ratings for the Veteran's degenerative disc disease at L4-5 and L5-S1, right shoulder condition, right elbow conditions, left knee osteoarthritis with meniscal tear, postmenopausal acne, and surgical scars of the lower back and right elbow. However, a 60 percent rating was granted for hypothyroidism prior to July 8, 2024, and TDIU from July 30, 2013.

The Board denied service connection for left knee patellofemoral pain syndrome and psoriasis, as the evidence did not support a finding that these conditions began during active service or are otherwise related to an in-service injury or disease.

The Board granted service connection for left and right knee osteoarthritis, a 30 percent rating for giardia lamblia, and a 30 percent rating for tinea versicolor. A total disability rating based on individual unemployability (TDIU) was also granted from February 15, 2019.

The veteran withdrew her appeal for all issues, including service connection and increased ratings.

The Veteran's service-connected disabilities have precluded him from securing and following substantially gainful employment, granting a total disability based on individual unemployability (TDIU).

The appeal for service connection for dermatophytosis (tinea pedis) was dismissed due to the Veteran's failure to file a timely appeal within one year of the November 2017 rating decision.

The Board granted earlier effective dates for the award of service connection for sleep apnea and nummular dermatitis, eczema, but denied a higher disability rating for left foot metatarsalgia fracture, with Morton's neuroma, hammer toes, hallux valgus, hallux rigidus, plantar fasciitis, pes planus and degenerative arthritis, and an initial disability rating in excess of 50 percent for sleep apnea.

The Board denied increased ratings for psoriasis and knee disabilities but granted a 60% rating from May 4, 2022, and 20% ratings from March 30, 2022, to May 4, 2022, for the Veteran's service-connected conditions.